About IBL International
IBL International is a company based in Mannedorf (Switzerland) founded in 1980 was acquired by Tecan in July 2014. IBL International operates in a competitive market with competitors including TGR BioSciences, Matriks Biotek, Optofluidic Bioassay, Elisabeth Biosciences and Lifespan Technologies, among others.
- Headquarter Mannedorf, Switzerland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of IBL International
Detailed funding history for IBL International
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in IBL International
IBL International has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Tecan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Automated laboratory instruments, robotics, and diagnostic solutions are provided.
|
Locked | Locked | Locked |
Investor details for IBL International
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IBL International
Investment portfolio details for IBL International
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - IBL International
Detailed financials for IBL International
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ibl International Comparisons
Peer comparison for IBL International
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IBL International
IBL International operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TGR BioSciences, Matriks Biotek, Optofluidic Bioassay, Elisabeth Biosciences and Lifespan Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Specializes in immunoassay technology
|
|
| Locked | Locked | Locked |
ELISA kits for monitoring biological drugs are developed and offered.
|
|
| Locked | Locked | Locked |
Proprietary microfluidic ELISA plates are provided for bioassays.
|
|
| Locked | Locked | Locked |
Elisabeth Biosciences manufactures and distributes ELISA kits for diagnostic applications.
|
|
| Locked | Locked | Locked |
Develops and sells ELISA kits for detecting carbohydrates in medical diagnostics.
|
Detailed competitors of IBL International
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ibl International
Complete news archive for IBL International
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IBL International
IBL International was founded in 1980.
IBL International is headquartered in Mannedorf, Switzerland. It is registered at Mannedorf, Zurich, Switzerland.
Founded in 1980 and based in Mannedorf, Switzerland, IBL International operates in the biotechnology sector, specializing in enzyme, radio, and luminescence immunoassays along with antibodies. These products support routine diagnosis in research, clinical, and specialty laboratories, with emphasis on areas such as endocrinology, neurodegeneration, infectious diseases, and autoimmunity. Distribution occurs online and through a global network.
IBL International's top competitors include TGR BioSciences, Matriks Biotek and Optofluidic Bioassay.
IBL International has 1 investor. Key investors include Tecan.